ÖZFİLİZ KILBAŞ, P. Et Al. 2018. The identification of protein expression profile of PC3 prostate cancer and PNTIA prostate epithelial cells following anti-obesity drug Orlistat treatment regardless of AMPK signaling. 6th International BAU Drug Design Congress , (İstanbul, Turkey), 120.

ÖZFİLİZ KILBAŞ, P., NEBİLER, E., ARISAN, E. D., ÇOKER GÜRKAN, A., OBAKAN YERLİKAYA, P., & ÜNSAL, Z. N., (2018). The identification of protein expression profile of PC3 prostate cancer and PNTIA prostate epithelial cells following anti-obesity drug Orlistat treatment regardless of AMPK signaling . 6th International BAU Drug Design Congress (pp.120). İstanbul, Turkey

ÖZFİLİZ KILBAŞ, PELİN Et Al. "The identification of protein expression profile of PC3 prostate cancer and PNTIA prostate epithelial cells following anti-obesity drug Orlistat treatment regardless of AMPK signaling," 6th International BAU Drug Design Congress, İstanbul, Turkey, 2018

ÖZFİLİZ KILBAŞ, PELİN Ö. Et Al. "The identification of protein expression profile of PC3 prostate cancer and PNTIA prostate epithelial cells following anti-obesity drug Orlistat treatment regardless of AMPK signaling." 6th International BAU Drug Design Congress , İstanbul, Turkey, pp.120, 2018

ÖZFİLİZ KILBAŞ, P. Et Al. (2018) . "The identification of protein expression profile of PC3 prostate cancer and PNTIA prostate epithelial cells following anti-obesity drug Orlistat treatment regardless of AMPK signaling." 6th International BAU Drug Design Congress , İstanbul, Turkey, p.120.

@conferencepaper{conferencepaper, author={PELİN ÖZFİLİZ KILBAŞ Et Al. }, title={The identification of protein expression profile of PC3 prostate cancer and PNTIA prostate epithelial cells following anti-obesity drug Orlistat treatment regardless of AMPK signaling}, congress name={6th International BAU Drug Design Congress}, city={İstanbul}, country={Turkey}, year={2018}, pages={120} }